| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2016-04-01 | Keryx Biopharmaceuticals (USA - NY) | nomination |
Renal diseases - Kidney diseases | Nomination | ||
| 2016-03-31 | Fusion Antibodies (UK) MAB Discovery (Germany) | monoclonal antibodies | R&D |
Technology - Services | R&D agreement | |
| 2016-03-31 | Txcell (France) | nomination |
Nomination | |||
| 2016-03-31 | Molmed (Italy) Takara Bio (Japan) | Zalmoxis® - investigational cell therapy product TK | termination of the agreement |
Cancer - Oncology - Rare diseases | Termination of the agreement | |
| 2016-03-31 | Array BioPharma (USA - CO) Asahi Kasei Pharma (Japan) | Tropomyosin receptor kinase A (TrkA) inhibitors, including Array-invented ARRY-954 | pain, inflammatory diseases and other undisclosed non-cancer indications | development collaboration |
Inflammatory diseases | Development agreement |
| 2016-03-30 | Epigenomics (Germany - USA) BioChain (USA - CA - China) | blood-based lung cancer test | lung cancer | licensing |
Cancer - Oncology - Diagnostic | Licensing agreement |
| 2016-03-30 | Vedanta Biosciences (USA - MA) RIKKEN (Japan) Azabu University (Japan) | pharmaceutical candidates involving bacterial strains that activate Th17 cells | licensing |
Cancer - Oncology - Immunological diseases - Infectious diseases | Licensing agreement | |
| 2016-03-30 | Curevac (Germany) | nomination |
Cancer - Oncology - Immunological diseases | Nomination | ||
| 2016-03-29 | MedImmune (USA - global biologics arm of AstraZeneca (UK) Inovio Pharmaceuticals (USA - PA) | INO-3112 | cancers caused by human papillomavirus (HPV) types 16 and 18 |
update licensing |
Cancer - Oncology - Infectious diseases | Licensing agreement |
| 2016-03-29 | Dassault Systèmes (France) Inserm (France) | 3DEXPERIENCE platform | collaboration |
Technology - Services | Collaboration agreement | |
| 2016-03-29 | MDxHealth (Belgium) Andros Men's Health Clinic (The Netherlands) | SelectMDx™ for Prostate Cancer test | prostate cancer | commercialisation |
Cancer - Oncology - Diagnostic | Commercialisation agreement |
| 2016-03-29 | Plasticell (UK) Sphere Fluidics (UK) | gene transduction technology | collaboration | Technology - Services | Collaboration agreement | |
| 2016-03-28 | Aduro Biotech (USA - CA) The University of California (UC) Berkeley (USA - CA) | Immunotherapeutics and Vaccine Research Initiative (IVRI) | collaboration R&D |
Autoimmune diseases - Cancer - Oncology - Infectious diseases | Collaboration agreement | |
| 2016-03-28 | Moderna Therapeutics (USA - MA) | nomination |
Nomination | |||
| 2016-03-26 | Medivation (USA - CA) | nomination |
Cancer - Oncology | Nomination | ||
| 2016-03-25 | UCB (Belgium) | nomination |
Nomination | |||
| 2016-03-25 | WuXi AppTec (China) | opening of new premises |
Technology - Services | Opening of new premises | ||
| 2016-03-24 | Bayer Healthcare (Germany) Regeneron Pharmaceuticals (USA - CA) | nesvacumab and aflibercept | ophtalmological diseases including wet age-related macular degeneration, diabetic macular edema | development collaboration |
Ophtalmological diseases | Development agreement |
| 2016-03-24 | ITM Isotopen Technologien München AG (ITM) (Germany) Scil Proteins (Germany) | targeted radio conjugates | collaboration |
Collaboration agreement | ||
| 2016-03-24 | 4SC (Germany) | resignation |
Cancer - Oncology | Resignation |
